Riskpilot← Back to searchSign inGet full accessINDUSTRIVEIEN 3 EIENDOM AS
ASActiveOrg 893425292Tomteveien 33, 1618 FredrikstadWholesale of pharmaceutical and medical goods · NACE 4646Est. 20080 employees
Revenue 2024
NOK 749K
+5% vs 2023
EBITDA margin
71.1%
-12% vs 2023
Equity ratio
12.8%
Financial strength
Net profit 2024
NOK 433K
-7% vs 2023
| Revenue | NOK 749K | +5% |
| EBITDA | NOK 532K | -12% |
| Net profit | NOK 433K | -7% |
| Total assets | NOK 2,8M | +17% |
| Equity | NOK 357K | +10% |
| Employees | 0 | — |
Legal name
INDUSTRIVEIEN 3 EIENDOM AS
Org number
893425292
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
18. desember 2008
Share capital
NOK 300 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Eie og drive egne faste eiendommer og andre investeringer herunder delta i andre selskaper herunder i aksjer og andeler.
Address
Tomteveien 33, 1618 Fredrikstad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 654 | 661 | 684 | 715 | 749 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 447 | 517 | 548 | 605 | 532 |
| Depreciation & amort. | −31 | −31 | −36 | −37 | −37 |
| EBIT | 417 | 486 | 513 | 569 | 495 |
| Net financials | 9 | 1 | 7 | 30 | 60 |
| Profit before tax | 425 | 487 | 520 | 598 | 556 |
| Tax | 94 | 107 | 114 | 132 | 122 |
| Net profit | 332 | 380 | 406 | 467 | 433 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 310 | 1 491 | 1 864 | 2 380 | 2 786 |
| Equity | 371 | 351 | 357 | 324 | 357 |
| Long-term debt | 57 | 57 | 56 | 54 | 52 |
| Short-term debt | 882 | 1 083 | 1 451 | 2 002 | 2 377 |
| Total debt | 938 | 1 139 | 1 507 | 2 056 | 2 429 |
EBITDA margin
71.1%
This company
15.8%
Market median
+350% vs market
20202024
Equity ratio
12.8%
This company
38.2%
Market median
-66% vs market
20202024
Return on equity
121.3%
This company
18.4%
Market median
+559% vs market
20202024
Net profit margin
57.9%
This company
8.1%
Market median
+615% vs market
20202024
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20202024
Debt / equity
6.80×
This company
0.62×
Market median
-997% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TS Deputy Member | Deputy Member | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medi Partner Holding As
INDUSTRIVEIEN 3 EIENDOM AS Board members of INDUSTRIVEIEN 3 EIENDOM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Trine-Lise Setterberg Andersen | Deputy Member | 0 companies |
| Lise Andrea Setterberg Nossen | Board of Directors | 0 companies |
| Lars Erik Andersen | Chairman | 0 companies |